scispace - formally typeset
L

Lynn E. Sullivan

Researcher at Yale University

Publications -  52
Citations -  4479

Lynn E. Sullivan is an academic researcher from Yale University. The author has contributed to research in topics: Buprenorphine & Acquired immunodeficiency syndrome (AIDS). The author has an hindex of 33, co-authored 52 publications receiving 4155 citations. Previous affiliations of Lynn E. Sullivan include National Institutes of Health & McLean Hospital.

Papers
More filters
Journal ArticleDOI

The prevalence and impact of alcohol problems in major depression: a systematic review.

Lynn E. Sullivan, +2 more
- 01 Apr 2005 - 
TL;DR: It is concluded that alcohol problems are more common in depression than in the general population, are associated with adverse clinical and health care utilization outcomes, and that antidepressants can be effective in the presence of alcohol dependence.
Journal ArticleDOI

Non-medical use, abuse and dependence on prescription opioids among U.S. adults: psychiatric, medical and substance use correlates.

William C. Becker, +4 more
- 01 Apr 2008 - 
TL;DR: Panic, social phobia and agoraphobia, low self-rated health status, and other substance misuse among those with non-medical use of prescription opioids should alert clinicians to screen for abuse and dependence.
Journal ArticleDOI

Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence

David A. Fiellin, +6 more
- 27 Jul 2006 - 
TL;DR: Among patients receiving buprenorphine-naloxone in primary care for opioid dependence, the efficacy of brief weekly counseling and once-weekly medication dispensing did not differ significantly from that of extended weekly Counseling and thrice-weekly dispensing.
Journal ArticleDOI

Drug Interactions of Clinical Importance among the Opioids, Methadone and Buprenorphine, and Other Frequently Prescribed Medications: A Review

Elinore F. McCance-Katz, +2 more
- 01 Jan 2010 - 
TL;DR: A substantial literature has accumulated on drug interactions between either methadone or buprenorphine with other medications when ingested concomitantly by humans and this review summarizes current literature in this area.
Journal ArticleDOI

HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite study

Frederick L. Altice, +14 more
- 01 Mar 2011 - 
TL;DR: Initiating BUP/NX in HIV clinical care settings is feasible and correlated with initiation of ART and improved CD4 lymphocyte counts, suggesting the need for multidisciplinary treatment strategies for this population of HIV-infected persons with opioid dependence.